Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model

References

• World Health Organization (WHO). Burden of COPD [online]. 2019 Available from: http://www.who.int/respiratory/copd/burden/en/. Accessed 612, 2020.
   Google Scholar
• VogelmeierC, CrinerG, MartinezF, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• National Council on Patient Information and Education. Enhancing prescription medicine adherence: a national action plan [online]. 2007 Available from: http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf. Accessed 612, 2020.
   Google Scholar
• RoglianiP, OraJ, PuxedduE, et al. Adherence to COPD treatment: myth and reality. Resp Med. 2017;129:117–123. doi:10.1016/j.rmed.2017.06.007
   PubMed Web of Science ®Google Scholar
• CromptonG, BarnesP, BroedersM, et al. The need to improve inhalation technique in Europe: a report from the aerosol drug management improvement team. Resp Med. 2006;100(9):1479–1494. doi:10.1016/j.rmed.2006.01.008
   PubMed Web of Science ®Google Scholar
• GenteneAJ, GuidoMR, WoolfB, et al. Multidisciplinary team utilizing pharmacists in multimodal, bundled care reduce chronic obstructive pulmonary disease hospital readmission rates. J Pharm Pract. 2019:089719001988944. doi:10.1177/0897190019889440
   Web of Science ®Google Scholar
• BlumlBM. White paper on expanding the role of pharmacists in chronic obstructive pulmonary disease: American Pharmacists Association Foundation. J Am Pharm Assoc. 2011;51(2):203–211. doi:10.1331/JAPhA.2011.11513
   Google Scholar
• ZhongH, NiX, CuiM, et al. Evaluation of pharmacist care for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Clin Pharm. 2014;36(6):1230–1240. doi:10.1007/s11096-014-0024-925330865
   PubMed Web of Science ®Google Scholar
• HeplerC, StrandL. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–543.2316538
   PubMedGoogle Scholar
• International Pharmaceutical Federation (FIP). Beating non-communicable diseases in the community: the contribution of pharmacists [online]. 2019 Available from: https://www.fip.org/files/content/publications/2019/beating-ncds-in-the-community-the-contribution-of-pharmacists.pdf. Accessed 126 2020.
   Google Scholar
• HallitS, ZeidanRK, SaadeS, et al. Knowledge, attitude and practice of lebanese community pharmacists toward chronic obstructive pulmonary disease. J Epidemiol Glob Health. 2020;10(1):86–95. doi:10.2991/jegh.k.191215.00432175715
   PubMed Web of Science ®Google Scholar
• SainiB. Role of community pharmacists in asthma – Australian research highlighting pathways for future primary care models. Aust Med J. 2011;4(4):190. doi:10.4066/AMJ.2011.790
   Google Scholar
• SuhajA, ManuMK, UnnikrishnanMK, VijayanarayanaK, MallikarjunaRC. Effectiveness of clinical pharmacist intervention on health-related quality of life in chronic obstructive pulmonary disorder patients - a randomized controlled study. J Clin Pharm Ther. 2016;41:78–83. doi:10.1111/jcpt.1235326775599
   PubMed Web of Science ®Google Scholar
• JarabAS, AlqudahSG, KhdourM, ShamssainM, MukattashTL. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012;34(1):53–62. doi:10.1007/s11096-011-9585-z22101426
   PubMed Web of Science ®Google Scholar
• EussenSR, ElstMEVD, KlungelOH, et al. A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. Ann Pharmacother. 2010;44(12):1905–1913. doi:10.1345/aph.1P28121119098
   PubMed Web of Science ®Google Scholar
• SainiB, KrassI, ArmourC. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother. 2004;38:1954–1960. doi:10.1345/aph.1E04515479780
   PubMed Web of Science ®Google Scholar
• SantschiV, ChioleroA, BurnandB, ColosimoAL, ParadisG. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011;171(16):1441–1453. doi:10.1001/archinternmed.2011.39921911628
   PubMedGoogle Scholar
• van der MolenT, van BovenJF, MaguireT, GoyalP, AltmanP. Optimizing identification and management of COPD patients–reviewing the role of the community pharmacist. Brit J Clin Pharmaco. 2017;83(1):192–201. doi:10.1111/bcp.13087
   PubMed Web of Science ®Google Scholar
• BarefieldKL, DeBellisHF. A review of health-related outcomes from community pharmacist interventions in patients with chronic obstructive pulmonary disease. J Am Col Clin Pharm. 2019;2(4):433–443. doi:10.1002/jac5.1151
   Google Scholar
• KozmaC, ReederC, SchulzR. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther. 1993;15(6):1121–1132.8111809
   PubMed Web of Science ®Google Scholar
• GourleyGA, PortnerTS, GourleyDR, et al. Part 3. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc. 1998;38(5):586–597.
   Google Scholar
• SolomonDK, PortnerTS, BassGE, et al. Part 2. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc. 1998;38(5):574–585.
   Google Scholar
• MoolaS, MunnZ, TufanaruC, et al. Joanna Briggs Institute Reviewer’s manual. The Joanna Briggs Institute. Chapter 7: systematic reviews of etiology and risk. [online] 2017 Available from: https://reviewersmanual.joannabriggs.org/. Accessed 126 2020.
   Google Scholar
• CastilloD, GuaytaR, GinerJ, et al. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Resp Med. 2009;103(6):839–845. doi:10.1016/j.rmed.2008.12.022
   PubMed Web of Science ®Google Scholar
• MehuysE, BousseryK, AdriaensE, et al. COPD management in primary care: an observational, community pharmacy-based study. Ann Pharmacother. 2010;44(2):257–266. doi:10.1345/aph.1M48120103611
   PubMed Web of Science ®Google Scholar
• HammerleinA, MullerU, SchulzM. Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. J Eval Clin Prac T. 2011;17(1):61–70. doi:10.1111/j.1365-2753.2010.01369
   PubMed Web of Science ®Google Scholar
• VermaA, HarrisonA, TorunP, VestboJ, EdwardsR, ThorntonJ. Are pharmacists reducing COPD’S impact through smoking cessation and assessing inhaled steroid use? Resp Med. 2012;106(2):230–234. doi:10.1016/j.rmed.2011.08.011
   PubMed Web of Science ®Google Scholar
• BeauchesneM-F, BercierD, Julien-BakerF, LalondeL, BoileauR, BlaisL. Community pharmacy–based medication assessment program for asthma and chronic obstructive pulmonary disease. Can Pharm J. 2012;145(2):70. doi:10.3821/145.2.cpj70
   Google Scholar
• PetkovaV, AndreevskaK, GueurguievS, et al. Community pharmacy-based program for patients with asthma and chronic obstructive pulmonary disease. Biotechnol Biotec Eq. 2012;26(6):3437–3442. doi:10.5504/BBEQ.2012.0099
   Web of Science ®Google Scholar
• FullerL, ConradWF, HeatonPC, PanosR, EschenbacherW, FredeSM. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting. J Am Pharm Assoc. 2012;52(5):E59–+. doi:10.1331/JAPhA.2012.11100
   Google Scholar
• TakemuraM, MitsuiK, MatsumotoIM, et al. Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients. Int J Chronic Obstr. 2013;8:239. doi:10.2147/COPD.S44022
   PubMed Web of Science ®Google Scholar
• TommeleinE, MehuysE, Van HeesT, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Brit J Clin Pharmaco. 2014;77(5):756–766. doi:10.1111/bcp.12242
   PubMed Web of Science ®Google Scholar
• TommeleinE, TollenaereK, MehuysE, BousseryK. Pharmaceutical care for patients with COPD in Belgium and views on protocol implementation. Int J Clin Pharm-Net. 2014;36(4):697–701. doi:10.1007/s11096-014-9956-3
   PubMed Web of Science ®Google Scholar
• OttenbrosS, TeichertM, de GrootR, et al. Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients. Int J Clin Pharm-Net. 2014;36(2):336–344. doi:10.1007/s11096-013-9887-4
   PubMed Web of Science ®Google Scholar
• CastilloD, BurgosF, GuaytaR, et al. Airflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosis. Respir Med. 2015;109(4):475–482. doi:10.1016/j.rmed.2015.02.00925754101
   PubMed Web of Science ®Google Scholar
• WrightD, TwiggM, BartonG, ThornleyT, KerrC. An evaluation of a multi-site community pharmacy-based chronic obstructive pulmonary disease support service. Inte J Pharm Pract. 2015;23(1):36–43. doi:10.1111/ijpp.12165
   PubMedGoogle Scholar
• BouwmeesterC, KraftJ, BungayKM. Optimizing inhaler use by pharmacist-provided education to community-dwelling elderly. Resp Med. 2015;109(10):1363–1368. doi:10.1016/j.rmed.2015.07.013
   PubMed Web of Science ®Google Scholar
• Apikoglu-RabusS, YesilyaprakG, IzzettinFV. Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease. Resp Med. 2016;120:109–115. doi:10.1016/j.rmed.2016.10.006
   PubMed Web of Science ®Google Scholar
• DavisE, MarraC, GambleJM, et al. Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial. Trials. 2016:17. doi:10.1186/s13063-016-1623-726745891
   PubMed Web of Science ®Google Scholar
• FathimaM, SainiB, FosterJM, ArmourCL. Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective. Int J Chronic Obstr. 2017;12:2753–2761. doi:10.2147/copd.S145073
   PubMed Web of Science ®Google Scholar
• DetoniKB, OliveiraIV, NascimentoMM, CauxTR, AlvesMR, Ramalho-de-OliveiraD. Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease. Int J Clin Pharm. 2017;39(1):95–103. doi:10.1007/s11096-016-0402-627915426
   PubMed Web of Science ®Google Scholar
• Castel-BrancoMM, FontesA, FigueiredoIV. Identification of inhaler technique errors with a routine procedure in Portuguese community pharmacy. Pharm Pract. 2017;15(4):1072. doi:10.18549/PharmPract.2017.04.1072
   PubMedGoogle Scholar
• HeikkilaJM, ParkkamakiS, SalimakiJ, WestermarckS, Pohjanoksa-MantylaM. Community pharmacists’ knowledge of COPD, and practices and perceptions of medication counseling of COPD patients. Int J Chronic Obstr. 2018;13:2065–2074. doi:10.2147/copd.S159726
   PubMed Web of Science ®Google Scholar
• RuudKW, RonningenSW, FaksvagPK, AriansenH, HovlandR. Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies. Patient Educ Couns. 2018;101(10):1828–1837. doi:10.1016/j.pec.2018.05.01829805072
   PubMed Web of Science ®Google Scholar
• AltonS, FarndonL. The impact of community pharmacy-led medicines management support for people with COPD. Brit J Commun Nurs. 2018;23(6):266–271. doi:10.12968/bjcn.2018.23.6.266
   PubMedGoogle Scholar
• KlassingHM, RuisingerJF, ProhaskaES, MeltonBL. Evaluation of pharmacist-initiated interventions on vaccination rates in patients with asthma or COPD. J Commun Health Nurs. 2018;43(2):297–303. doi:10.1007/s10900-017-0421-9
   Web of Science ®Google Scholar
• FathimaM, SainiB, FosterJM, ArmourCL. A mixed methods analysis of community pharmacists’ perspectives on delivering COPD screening service to guide future implementation. Res Social Adm Pharm. 2019;15(6):662–672. doi:10.1016/j.sapharm.2018.08.00730131254
   PubMed Web of Science ®Google Scholar
• HessoI, KayyaliR, Nabhani-GebaraS. Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London. BMC Health Serv Res. 2019;19:5. doi:10.1186/s12913-018-3814-230611264
   PubMed Web of Science ®Google Scholar
• CassetA, Meunier-SpitzM, RebotierP, et al. Asthma management and inhalation techniques among community pharmacists in 2009: a comparison with the 1999 survey. J Asthma. 2014;51(9):964–973. doi:10.3109/02770903.2014.93644624986249
   PubMed Web of Science ®Google Scholar
• BischoffEW, HamdDH, SedenoM, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax. 2011;66(1):26–31. doi:10.1136/thx.2009.12762121037270
   PubMed Web of Science ®Google Scholar
• HuntV, AndersonD, LowrieR, et al. A non-randomised controlled pilot study of clinical pharmacist collaborative intervention for community dwelling patients with COPD. Npj Prim Care Resp M. 2018;28(1):1–10.
   PubMedGoogle Scholar
• ChoKH, KimYS, NamCM, et al. The association between continuity of care and all-cause mortality in patients with newly diagnosed obstructive pulmonary disease: a population-based retrospective cohort study, 2005–2012. PLoS One. 2015;10(11). doi:10.1371/journal.pone.0141465
   Web of Science ®Google Scholar
• TanEC, StewartK, ElliottRA, GeorgeJ. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. RSAP. 2014;10:608–622. doi:10.1016/j.sapharm.2013.08.00624161491
   PubMed Web of Science ®Google Scholar
• JorgensonD, LaubscherT, LyonsB, PalmerR. Integrating pharmacists into primary care teams: barriers and facilitators. Int J Pharm Pract. 2014;22:292–299. doi:10.1111/ijpp.1208024279947
   PubMedGoogle Scholar
• TraynorK. Pharmacist fits on high-intensity transitional care team. Am J Health Syst Pharm. 2014;71(13):1066–1068. doi:10.2146/news14004724939493
   PubMed Web of Science ®Google Scholar
• Moltó-PuigmartíC, VonkR, van OmmerenG, HeggerI. A logic model for pharmaceutical care. J Health Serv Res Policy. 2018;23(3):148‐157. doi:10.1177/1355819618768343
   PubMed Web of Science ®Google Scholar
• El HajjMS, KheirN, Al MullaAM, ShamiR, FanousN, MahfoudZR. Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial. BMC Public Health. 2017;17(1):215. doi:10.1186/s12889-017-4103-428219367
   PubMed Web of Science ®Google Scholar
• SchommerJC, KucukarslanSN. Measuring patient satisfaction with pharmaceutical services. Am J Health Syst Ph. 1997;54(23):2721–2732.
   PubMed Web of Science ®Google Scholar
• NaikP, SainiB, ArmourC. Measurement of patient satisfaction with community pharmacy services: a review. Pharm World Sci. 2009;31:525–537. doi:10.1007/s11096-009-9311-219588267
   PubMedGoogle Scholar
• GuptaKS, RokadeV. Importance of quality in health care sector: a review. J Health Manag. 2016;18(1):84–94. doi:10.1177/0972063415625527
   Web of Science ®Google Scholar
• SchuesslerTJ, RuisingerJF, HareSE, ProhaskaES, MeltonBL. Patient satisfaction with pharmacist-led chronic disease state management programs. J Pharm Pract. 2016;29(5):484–489. doi:10.1177/089719001456867225670545
   PubMedGoogle Scholar
• SchumockGT, MeekPD, PloetzPA, VermeulenLC. Economic evaluations of clinical pharmacy services(1988–1995). Pharmacotherapy. 1996;16:1188–1208.8947994
   PubMed Web of Science ®Google Scholar
• PerezA, DolorescoF, HoffmanJM, et al. Economic evaluations of clinical pharmacy services 2001–2005. Pharmacotherapy. 2009;29(1):128. doi:10.1592/phco.29.1.12819113803
   PubMedGoogle Scholar
• MurrayME, BarnerJC, PopeND, ComfortMD. Impact and feasibility of implementing a systematic approach for medication therapy management in the community pharmacy setting: a pilot study. J Pharm Pract. 2019;32(6):664–670. doi:10.1177/089719001877984729865973
   PubMed Web of Science ®Google Scholar
• Chisholm-BurnsMA, Graff ZivinJS, LeeJK, et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review, Am J Health Syst Pharm. 2010;67(19):1624–1634. doi:10.2146/ajhp10007720852164
   PubMed Web of Science ®Google Scholar
• BenrimojSI, LangfordJH, BerryG, et al. Economic impact of increased clinical intervention rates in community pharmacy. Pharmacoeconomics. 2000;18(5):459–468. doi:10.2165/00019053-200018050-0000511151399
   PubMed Web of Science ®Google Scholar
• FélixJ, FerreiraD, Afonso-SilvaM, et al. Social and economic value of Portuguese community pharmacies in health care. BMC Health Serv Res. 2017;17(1):606. doi:10.1186/s12913-017-2525-428851428
   PubMed Web of Science ®Google Scholar
• BourbeauJ, GranadosD, RozeS, et al. Cost-effectiveness of the COPD patient management European trial home-based disease management program. Int J Chronic Obstr. 2019;14:645. doi:10.2147/COPD.S173057
   PubMed Web of Science ®Google Scholar
• StewartDW, BrownSD, ClavierCW, WyattJ. Active-learning processes used in US pharmacy education. Am J Pharm Educ. 2011;75:68. doi:10.5688/ajpe7546821769144
   PubMed Web of Science ®Google Scholar
• DoucetteWR, NevinsJC, GaitherC, et al. Organizational factors influencing pharmacy practice change. Res Soc Admin Pharm. 2012;8(4):274–284. doi:10.1016/j.sapharm.2011.07.002
   PubMed Web of Science ®Google Scholar